Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiency.
about
Residual N-acetyl-α-glucosaminidase activity in fibroblasts correlates with disease severity in patients with mucopolysaccharidosis type IIIBThe Newborn Screening Paradox: Sensitivity vs. Overdiagnosis in VLCAD DeficiencyVery Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency and Perioperative Management in Adult Patients.Prediction of phenotypic severity in mucopolysaccharidosis type IIIA.Clinical, Biochemical, and Molecular Features in 37 Saudi Patients with Very Long Chain Acyl CoA Dehydrogenase Deficiency.Profiling of intracellular metabolites produced from galactose and its potential for galactosemia research
P2860
Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiency.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiency.
@en
Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiency.
@nl
type
label
Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiency.
@en
Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiency.
@nl
prefLabel
Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiency.
@en
Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiency.
@nl
P2093
P2860
P50
P356
P6366
P1433
P1476
Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiency.
@en
P2093
Eugene F Diekman
Frits A Wijburg
Gepke Visser
Hans R Waterham
Jos P N Ruiter
Lodewijk Ijlst
Ludo van der Pol
Ronald J Wanders
Sacha Ferdinandusse
Sander M Houten
P2860
P2888
P304
P356
10.1038/GIM.2015.22
P407
P577
2015-04-02T00:00:00Z
P6179
1006023220
P6366
2039272206